2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Angiofibroma: new trials by email Literature Review of Angiofibroma trials Research Report on Angiofibroma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC) NPC-12G gel, Placebo gel - Tuberous Sclerosis, Angiofibroma | Phase 3 | Completed | Nobelpharma | 62 | 2015-12-01 | 2017-02-02 |
| Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex NPC-12G gel - Tuberous Sclerosis, Angiofibroma | Phase 3 | Completed | Nobelpharma | 94 | 2015-12-01 | 2019-02-20 |
Plaque, Amyloid (2) · Tuberous Sclerosis (2)
Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hamartoma (2) · Heredodegenerative Disorders, Nervous System (2) · Malformations of Cortical Development (2) · Malformations of Cortical Development, Group I (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Multiple Primary (2) · Neoplasms, Vascular Tissue (2) · Neoplastic Syndromes, Hereditary (2) · Nervous System Diseases (2) · Nervous System Malformations (2) · Neurocutaneous Syndromes (2)
Nobelpharma (2)
Japan (2)
Mari Wataya-Kaneda, MD, PhD (1) · Mari Wataya-Kaneda,, MD, PhD (1)